MINIMAL EFFICACY OF A DEPLETING CHIMERIC ANTI-CD4 (CM-T412) IN TREATMENT OF PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA) RECEIVING CONCOMITANT METHOTREXATE (MTX)
L. Moreland et al., MINIMAL EFFICACY OF A DEPLETING CHIMERIC ANTI-CD4 (CM-T412) IN TREATMENT OF PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA) RECEIVING CONCOMITANT METHOTREXATE (MTX), Arthritis and rheumatism, 36(9), 1993, pp. 190000039-190000039